This invention facilitates the realization of optical elements with spatially multiplexed/interleaved phase profiles to achieve a high packing density of distinct optical elements on a surface.
Researchers at Stanford University have identified molecular regulators that can act as part of a personalized treatment plan to help treat hormone-related conditions, including pregnancy and infertility.
Despite their rapidly expanding therapeutic potential, human pluripotent stem cell (hPSC)-derived cell therapies continue to have serious safety risks.
Researchers at Stanford have developed a dielectric diffraction grating that provides high (near-unity) diffraction efficiencies in an ultra-compact volume.
Stanford researchers at the Thakor Lab have developed methods for kidney tissue regeneration using pulsed focused ultrasound (pFUS) therapy with mesenchymal stromal cells (MSCs) and/or MSC-derived extracellular vesicles (e.g., exosomes or microvesicles).
Our researcher has developed a mouse model of 16p11.2 deletion syndrome. A copy number variation on human chromosome 16p11.2 is among the most common genetic variations found in autism spectrum disorders.
Genetic engineering of biological systems is a fundamental tool for both basic and translation research, where up- and down-regulation of gene expression is necessary to drive cellular phenotypes and evaluate gene function.
The emergence of SARS-CoV-2 variants during the COVID-19 pandemic has demonstrated a need for broad immunization, such as provided by multivalent vaccines.
Researchers in the Appel lab have developed hydrogels for tumor inoculation that improve precision and statistical power in preclinical mouse models of cancer.
Researchers at Stanford have found that nascent polypeptide-associated complex (NAC) and the apical domain of CCT1, as well as peptide fragments and fusion proteins containing them, can be used to suppress pathological protein aggregation.
Stanford researchers have constructed a microbial cell factory by genetically modifying the bacterium Methylomicrobium alcaliphilum 20Z to convert methanol and methane into para-hydroxybenzoic acid (p-HBA).
Jennifer Cochran and Carolyn Bertozzi have collaborated to develop a bifunctional molecule called a polyspecific integrin-binding peptide (PIP)-LYTAC that can bind to integrins expressed on the surface of cancer cells and trigger their degradation via the lysosome.